XML 23 R7.htm IDEA: XBRL DOCUMENT

1. NATURE OF BUSINESS AND GOING CONCERN	12 Months Ended
May 31, 2014
Notes to Financial Statements
1. NATURE OF BUSINESS AND GOING CONCERN	Nature of Business: Lescarden Inc. (the "Company") is engaged in the research, testing and development of medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies. Going Concern: The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of assets and the satisfaction of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the financial statements, the Company had net loss of $176,210 for the year ended May 31, 2014, a stockholders’ deficiency and a working capital deficiency. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s major stockholder is uncertain about his ability to continue providing loans to the Company as needed to fund operating expenses until the Company can restore productive capacity and return to profitability. The Company’s plan and ability to continue as a going concern is primarily dependent upon the majority shareholder’s ability to continue funding losses until the Company is able to re-establish production operations.

1. NATURE OF BUSINESS AND GOING CONCERN

12 Months Ended

May 31, 2014

Nature of Business:

Lescarden Inc. (the "Company") is engaged in the research, testing and development of medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies.

Going Concern:

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of assets and the satisfaction of liabilities that might be necessary should the Company be unable to continue as a going concern.

As shown in the financial statements, the Company had net loss of $176,210 for the year ended May 31, 2014, a stockholders’ deficiency and a working capital deficiency. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s major stockholder is uncertain about his ability to continue providing loans to the Company as needed to fund operating expenses until the Company can restore productive capacity and return to profitability.

The Company’s plan and ability to continue as a going concern is primarily dependent upon the majority shareholder’s ability to continue funding losses until the Company is able to re-establish production operations.